Four New Carvotanacetone Derivatives from Sphaeranthus ukambensis, Inhibitors of the Ubiquitin-Proteasome Pathway

Abstract

Six carvotanacetone derivatives (1–6), amongst which four new compounds (1–4), were isolated from the aerial parts of Sphaeranthus ukambensis Vatke & O. Hoffm. The structures of the molecules were elucidated by complementary spectroscopic methods, and their biological properties were investigated using human DLD-1 colon cancer cells engineered to stably express a 4 ubiquitin-luciferase (4 Ub-Luc) reporter protein. Five of the isolated carvotanacetone derivatives (2–6) were found to inhibit the proliferation of the colon cancer cells and interfere with the ubiquitin-proteasome pathway, with potencies in a micromolar range.

Supporting information available online at http://www.thieme-connect.de/ejournals/toc/plantamedica

carvotanacetone - Sphaeranthus ukambensis - Compositae - ubiquitin‐proteasome pathway - cancer

References

• 1 Ragasa C Y, Tsai P W, Galvez C T, Shen C-C. New carvotanacetone derivatives from Sphaeranthus africanus.  Planta Med. 2010;  76 146-151
• 2 Jakupovic J, Grenz M, Bohlmann F, Mungai G M. Carvotacetone derivatives and eudesman-12, 6β-olides from Sphaeranthus species.  Phytochemistry. 1990;  29 1213-1217
• 3 Zdero C, Bohlmann F, Mungai G M. Carvotacetone derivatives and other constituents from representatives of the Sphaeranthus group.  Phytochemistry. 1991;  30 3297-3303
• 4 Eid F, El-Dahmy S. Carvotanacetone derivatives from Sphaeranthus suaveolens.  Pharmazie. 1988;  43 347-348
• 5 Ahmed A A, Mahmoud A A. Carvotacetone derivatives from the Egyptian plant Sphaeranthus suaveolens.  Phytochemistry. 1997;  45 533-535
• 6 Beentje H J ed.. Flora of tropical East Africa, Compositae (Part 2). Kew; Royal Botanic Gardens 2002: 370-391
• 7 Kokwaro J O. Medicinal plants of East Africa. 2nd edition. Nairobi; Kenya Literature Bureau 1993: 82-83
• 8 Gradé J T, Tabuti J R S, Van Damme P. Ethnoveterinary knowledge in pastoral Karamoja, Uganda.  J Ethnopharmacol. 2009;  122 273-293
• 9 Vandenberghe I, Créancier L, Vispé S, Annereau J P, Barret J M, Pouny I, Samson A, Aussagues Y, Massiot G, Ausseil F, Bailly C, Kruczynski A. Physalin B, a novel inhibitor of the ubiquitin-proteasome pathway, triggers NOXA-associated apoptosis.  Biochem Pharmacol. 2008;  76 453-462
• 10 Testa U. Proteasome inhibitors in cancer therapy.  Curr Drug Targets. 2009;  10 968-981